Surrogate End Points and Their Validation in Oncology Clinical Trials

MeSH terms

• Biomarkers / analysis*
• Biomarkers, Tumor / analysis*
• Biomarkers, Tumor / standards
• Clinical Trials, Phase III as Topic / methods*
• Clinical Trials, Phase III as Topic / standards
• Humans
• Neoplasms / chemistry*
• Neoplasms / therapy*
• Randomized Controlled Trials as Topic / methods*
• Randomized Controlled Trials as Topic / standards
• Reproducibility of Results